Cancer Prevention Grants

Cancer Public Education Project Grant

Awards: Up to $5,000 available for funding.

Purpose: To enhance the public's knowledge and awareness of cancer prevention, detection, and treatment modalities.

Selection Criteria: The candidate must have a current license to practice as a registered nurse and must have an interest in and commitment to oncology nursing. The major focus of the project should be some aspect of cancer public education.

Application deadline: June 15, 2011

Oncology Nursing Society Foundation
125 Enterprise Drive
Pittsburgh, PA 15275-1214
(412) 859-6100
(412) 859-6163
foundation@ons.org

Oncology Nursing Society Excellence in Cancer Prevention and Early Detection Award

Award: Monetary award of $1000 and a plaque.

Purpose: To recognize and support excellence in nurses engaged in cancer prevention and early detection.

Nominee's Eligibility Criteria:
The candidate must meet the following criteria:

Be a registered professional nurse and an active ONS member
Have at least two years of oncology nursing experience
Be a recognized expert in the field of cancer prevention and early detection (e.g., through publications, presentations, research, and peer review)
Made a significant contribution to one or more of the following related to cancer prevention and early detection: professional/patient education, clinical practice, and/or nursing research
Serves as a role model for other nurses.

Criteria:
The scoring criteria for judging this nomination packet is as follows:

ONS involvement: Participation should include involvement at the local or national level.
Includes membership on committees, holding office, or task force participation.
Recognized expert in the field of cancer prevention and early detection, contributing to the development of cancer prevention and early detection.
Includes articles in newsletters, journals, reports, video, multimedia, computer assisted instruction, chapters in books (do not include research here, include research in last criteria point)
Significant contribution to the following areas:
Professional/patient education related to cancer prevention and early detection
Presentations
Examples in letters of role modeling
Specific educational interventions
Program development
Support groups
Adjunct faculty to preceptor for students
Community outreach
Clinical practice related to cancer prevention and early detection:
Theoretical concepts used
Nursing process used
Professional development of self and others
Multidisciplinary collaboration
Quality assurance
Ethical decision-making used
Reviews/applies nursing research
Cancer prevention and early detection research

Application deadline: October 31, 5pm ET.

Oncology Nursing Society
125 Enterprise Drive
Pittsburgh, PA 15275

866-257-4ONS (866-257-4667)
412-859-6100
877-369-5497 (toll free fax)
412-859-6162 (fax)
customer.service@ons.org

Lymphoma Research Foundation 2011-2013 Postdoctoral Fellowships

$105K for 2 years

The Lymphoma Research Foundation (LRF) seeks applications for its 2-year Postdoctoral Fellowship award. Projects may be laboratory or clinic based, with the results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/of non-Hodgkin lymphoma. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies and transplantation.

* Applications are due on September 7, 2010. Applications will be peer-reviewed, and applicants will be notified of results by November 2010.

Application Receipt Date: Sept 7, 2010
Peer Review Process: Sept 2010 – Oct 2010
Applicant Notification Date: Nov 2010
Earliest Project Start Date: Jan 1, 2011

PURPOSE OF FELLOWSHIP
To support research, which may be laboratory or clinic based, with the results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin’s and/or non-Hodgkin’s lymphoma. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies, and transplantation.

ELIGIBILITY
1. Applicants must have completed two years of their fellowship, or not more than two years as a junior faculty instructor or assistant professor at the start of the award period and hold an M.D., Ph.D., or equivalent degree.
2. Applicants must be affiliated with a sponsoring institution in the U.S. or Canada for the duration of the LRF Grant. Citizenship is not required.
3. Applicant must secure a Sponsor who will supervise the proposed research project. The Sponsor’s role is to assure (on behalf of the Institution) that the specific aims of the project are met and to present the Institution’s role in the development of the Applicant’s career. The Sponsor may support only one applicant.
4. Applications are encouraged from qualified individuals without regard to age, race, religion, sex, creed, national origin, or any other characteristics protected by law.
5. All LRF applications are self-initiated. LRF does not invite applications from selected individuals or laboratories.
6. The Fellow must spend a minimum of 80 percent of his/her time in research without major patient care, teaching, or administrative responsibilities except as such responsibilities relate directly to a pre-clinical or clinical lymphoma research project.
7. The LRF Fellow may not hold another competitively applied for fellowship title during the period of the LRF Grant. However, LRF Grants may be supplemented by funds from other sources. LRF must be informed as to the sources and the amounts of all other funding received by the LRF Fellow during the term of the LRF Grant. Failure to comply may result in termination of the LRF Grant.
8. There is no restriction on the number of times an individual may apply for an LRF Grant.
9. A previous LRF Fellow shall not be granted support other than in exceptional circumstances, which is decided on a case-by-case basis.

In our efforts to improve our grant process, the Lymphoma Research Foundation will be using an electronic grants submission process. All interested grant applicants must submit their applications online through proposalCENTRAL (https://proposalcentral.altum.com).

To avoid being rushed at deadline time, applicants are encouraged to register and complete a professional profile at proposalCENTRAL now. Applicants should make sure their grants and contracts office has registered their institution and signing officials with proposalCENTRAL.

New York Office:
115 Broadway, 13th Floor
New York, NY 10006
Phone: (212) 349-2910, (800) 235-6848
Fax: (212) 349-2886

Los Angeles Office:
8800 Venice Blvd, Suite 207
Los Angeles, CA 90034
Phone: (310) 204-7040, (800) 500-9976
Fax: (310) 204-7043

Leukemia & Lymphoma Society's Career Development Program

The Leukemia & Lymphoma Society's (LLS's) Career Development Program (CDP) provides awards intended to meet the specific needs of investigators at different states in their research careers. The awards - Scholar, Scholar in Clinical Research, Special Fellow, Special Fellow in Clinical Research and Fellow - provide stipends to investigators, allowing them to devote themselves to research bearing on leukemia, lymphoma and myeloma.

The CDP supports fundamental research in genetics, molecular and cell biology, molecular pharmacology, molecular virology and immunology. The program also encompasses translational research directly relevant to the improved treatment or diagnosis of leukemia, lymphoma, myeloma and, where applicable, to prevention.

Effective Award Year 2011

Scholar
Scholars are highly qualified investigators who have shown a capacity for independent, sustained original investigation in the field of leukemia, lymphoma, and myeloma. These Scholars are expected to hold independent faculty-level or equivalent positions and have obtained substantial support for their research from a national agency. Scholar awards are for up to $110,000 per year for five years. Annual renewals are based on a non-competitive progress report review.

Scholar in Clinical Research
Scholars in Clinical Research are highly qualified investigators who are expected to hold independent faculty-level appointments and who are conducting original, independent applied research, often involving early-stage clinical trials which will advance the prevention, diagnosis or treatment of hematologic malignancies. These Scholars are expected to have concomitant support for their research from another source or agency. Scholar in Clinical Research awards are for up to $110,000 per year for five years. Annual renewals are based on a non-competitive progress report review.

Special Fellow
Special Fellows are qualified investigators who have completed a minimum of two years of postdoctoral research training and are continuing their research under the direction of a research Sponsor. The Special Fellowship should permit the scientist to begin to transition to an independent research program. Special Fellow awards are for up to $65,000 per year for three years. Annual renewals are based on a non-competitive progress report review.

Special Fellow in Clinical Research (SFCR)
Special Fellows are researchers who hold a Ph.D., M.D. or equivalent degree and have completed a minimum of two years of clinical hematology, oncology, hematology/oncology or hematopathology training or postdoctoral research training in a clinical discipline (e.g., cytogenetics, molecular pathology). These grantees should provide evidence that their career focus will be on the prevention, diagnosis, or treatment of leukemia, lymphoma, or myeloma. SFCR awards are for up to $65,000 per year for three years. Annual renewals are based on a non-competitive progress report review.

Fellow
Fellows are promising investigators with less than two years of postdoctoral research training. These grantees are encouraged to embark on an academic career involving clinical or fundamental research in, or related to, leukemia, lymphoma or myeloma under the direction of a research sponsor. Fellow awards are for up to $55,000 per year for three years. Annual renewals are based on a non-competitive progress report review.

Deadlines
A letter of intent is mandatory for those applying for a Career Development Program grant and must be completed online via proposalCentral by 3 p.m. ET, Sept. 15.

Full applications must be received electronically via proposalCentral by 3 p.m. ET, Oct. 1.

Our program is now open. Please apply via proposalCENTRAL.

For more program information, contact:

The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605
Telephone: (914) 821-8301, (914) 821-8290, researchprograms@lls.org .

International Agency for Research on Cancer Expertise Transfer Fellowship

The International Agency for Research on Cancer (IARC) is the specialized cancer Agency of the World Health Organization (WHO). Situated in Lyons, France, the IARC houses both epidemiology and laboratory Groups allowing it to fulfil its mission: to coordinate and conduct research on the causes of human cancer, to elucidate the mechanisms of carcinogenesis and to develop scientific strategies for cancer control.

The IARC is offering an Expertise Transfer Fellowship to enable an established investigator to spend normally from six to twelve months in an appropriate host institute in a low- / medium-resource country* in order to transfer knowledge and expertise in a research area relevant for the host country and related to the Agency's programmes. The major areas of activity are focused on understanding cancer etiology (including infections, nutrition, lifestyle, environment, radiation, genetics), developing strategies for cancer prevention (primary prevention, screening) and elucidating the underlying mechanisms of carcinogenesis through studies of molecular and cell biology, molecular genetics, epigenetics and molecular pathology. The Agency also has strong programmes dedicated to describing the global cancer burden and to the evaluation of carcinogenicity through its Monographs Programme. There is an emphasis on interdisciplinary work in the Agency's research activities.

Applications should include a proposed collaborative research project, specifying the link to IARC's on-going activities and a letter of support from the host lab giving details of feasibility and anticipated benefit to the receiving institute. A letter of endorsement from a research Group at IARC must also be provided. Priority will be given to projects directly linked to IARC's on-going research programme, involving at least one contact at IARC.
Applicants should be established cancer researchers actively engaged in the field with appropriate scientific or medical qualifications and an excellent publications' record. They must also belong to the staff of a university or a research institution.

Deadline for receipt of applications is: 30 November 2010 . Candidates will be notified of the outcome of their application by the end of April 2011. There will be an annual remuneration of up to US$70,000, which will take into account the on-going salary of the Fellow. This amount may include limited support for the project. The cost of travel will also be met. The Award should be taken up no later than 30 November 2011.

(*any country other than those classified as high-income economies by the World Bank )

Fellowship application forms and more detailed information are available from:

Fellowship Programme
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
150 cours Albert-Thomas, 69372 Lyon Cedex 08, France
Tel: +33 (0)472 73 84 48; Fax: +33 (0)472 73 80 80; E-mail: fel@iarc.fr
Internet: http://www.iarc.fr

International Agency for Research on Cancer Fellowships for Cancer Research

Applications must reach the Agency no later than 30 November 2010

Applications for training fellowships in 2011-2012 are invited from junior scientists wishing to complete their training in those aspects of cancer research related to the Agency's mission: to coordinate and conduct both epidemiological and laboratory research into the causes and prevention of cancer. Disciplines covered are: epidemiology (including genetic and molecular), biostatistics, bioinformatics, and areas related to mechanisms of carcinogenesis including molecular and cell biology, molecular genetics, epigenetics, and molecular pathology. There is an emphasis on interdisciplinary projects.

Fellowships are tenable at the IARC in Lyon, France working in a research Group. Applicants are eligible from any country. The IARC is particularly keen to promote the development of expertise in cancer research in low- and medium-resource countries by training postdoctoral researchers from these countries who can return to apply their new skills and expertise. Therefore, applications from candidates from low- and medium-resource countries or applicants from any part of the world but with projects related to low- and medium-resource countries are encouraged. The fellowship is for a period of one year, with the possibility of an extension for a second year subject to satisfactory appraisal. Candidates are required to have spent less than five years abroad (including doctoral studies) and have finished their doctoral degree within five years of the closing date for application or be in the final phase of completing their doctoral degree (M.D. or Ph.D.). The working languages at IARC are English and French. Candidates must be proficient in English at a level sufficient for scientific communication. Candidates already working as a postdoctoral fellow at the Agency at the time of application or who have had any contractual relationship with IARC during the six months preceding the application deadline or who have already spent more than one year at IARC cannot be considered. Candidates must contact the host Group of their choice at IARC before application in order to interact closely to establish a proposed programme of mutual interest. Contact with the Group Heads can be made through the Agency's web site: http://www.iarc.fr

Fellowships must be taken up by 30 November 2011. The annual stipend is currently 31 860 Euros. The cost of travel for the Fellow, and in certain circumstances for dependants, will be met, a dependant's allowance paid, and health insurance covered.

Fellowship application forms and more detailed information are available from:
Fellowship Programme
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
150 cours Albert-Thomas, 69372 Lyon Cedex 08, France
Tel: +33 (0)472 73 84 48; Fax: +33 (0)472 73 80 80; E-mail: fel@iarc.fr
Internet: http://www.iarc.fr

International Agency for Research on Cancer Visiting Scientist Award for Senior Scientists

The International Agency for Research on Cancer (IARC) is the specialized cancer Agency of the World Health Organization (WHO). Situated in Lyon, France, the IARC houses both epidemiology and laboratory Groups allowing it to fulfil its mission: to coordinate and conduct research on the causes of human cancer, to elucidate the mechanisms of carcinogenesis and to develop scientific strategies for cancer control.

The Agency is offering the exciting opportunity of an IARC Senior Visiting Scientist Award. This Award is for a qualified and experienced senior investigator with recent publications in international peer-reviewed scientific journals who wishes to spend from six to twelve months at the IARC working on a collaborative project in a research area related to the Agency's programmes. The major areas of activity are focused on understanding cancer etiology (including infections, nutrition, lifestyle, environment, radiation, genetics), developing strategies for cancer prevention (primary prevention, screening) and elucidating the underlying mechanisms of carcinogenesis through studies of molecular and cell biology, molecular genetics, epigenetics and molecular pathology. The Agency also has strong programmes dedicated to describing the global cancer burden and to the evaluation of carcinogenicity through its Monographs Programme. There is an emphasis on interdisciplinary work in the Agency's research activities.

Candidates are requested to contact the relevant Scientific Groups in order to set up a collaborative project. For details on scientific programmes and research groups please consult the IARC Web site: http://www.iarc.fr, or contact the IARC at the address below.

Applicants must belong to the staff of a university or a research institution and should provide written assurance of a post to return to at the end of the period of award.

Deadline for receipt of applications is: 30 November 2010. Candidates will be notified of the outcome of their application by the end of April 2011. There will be an annual remuneration of up to US$80,000-, which will take into account the on-going salary of the visiting scientist plus the cost of travel. The Award should be taken up no later than 30 November 2011.

Fellowship application forms and more detailed information are available from:

Fellowship Programme
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
150 cours Albert-Thomas, 69372 Lyon Cedex 08, France
Tel: +33 (0)472 73 84 48; Fax: +33 (0)472 73 80 80; E-mail: fel@iarc.fr
Internet: http://www.iarc.fr

National Lung Cancer Partnership 2011 Young Investigator Research Grant Request for Applications

National Lung Cancer Partnership is currently supporting a Young Investigator Research Grant for junior clinical and basic investigators

Applications deadline September 10, 2010

Purpose of Grant
The purpose of this Grant Program is to drive research forward that will increase understanding of lung cancer risk, biology, and response to treatment, while ensuring that young investigators have the resources needed for them to succeed as lung cancer researchers. For 2010, multiple grants are available. Research that will aid in prevention, detection, diagnosis, screening, treatment, and symptom management of lung cancer is sought.

The Young Investigator Research Grant is intended as seed money for young investigators to carry out promising novel research in any facet of lung cancer. Applications pertaining to sex differences in lung cancer are particularly encouraged. The Grant will be awarded for one or two years, for up to $50,000 direct expenses per year ($100,000 maximum over 2 years). The Grant is designed to be used primarily for research support, including technical assistance, supplies, reagents, and equipment. An additional 8% of the award amount may be requested to cover indirect costs or institutional overhead to the Grant recipient’s institution.

Applications will be judged on the quality of the applicant’s research, feasibility of the Career Development Plan, and the resources and environment available to the applicant, including the ability of the primary mentor to provide appropriate guidance and protected time during the Grant period.

Eligibility
1. At the time of application, an applicant must hold a doctoral degree (MD, PhD, DO, DrPH,
or equivalent), and be a post-doctoral fellow or be in the first 5 years of a faculty appointment at a not-for-profit institution. Pre-doctoral fellows are not eligible for the Young
Investigator Research Grant.
2. Applications will only be accepted from individuals involved in lung cancer research. Applications addressing sex differences in lung cancer are especially encouraged.
3. Applications will be accepted from individuals at US and Canadian sponsoring institutions. The applicant need not be a citizen of either country. If the applicant is not a US or Canadian citizen, verification of work visa must be provided with the application.
4. There must be a Primary Mentor at the applicant’s institution who will oversee the applicant’s Career Development Plan. The Primary Mentor may only support one applicant.
5. The Young Investigator Research Grant recipient must spend a minimum of 50 percent of her/his time in lung cancer research during the grant period. This time should be free from major non-research focused patient care, teaching, administrative, or other responsibilities.
6. Young Investigator Research Grant recipients may hold any other fellowship, award, or grant during the time of the award.
7. Young Investigator Research Grant recipients and their primary mentor may not have knowingly received any research funding from the tobacco industry, its parent companies, or subsidiaries, within the last 5 years.
8. Applications involving animals must receive approval from the institution’s Animal Care and Use Committee before award commencement.
9. Applications involving human participants must receive approval from the local Institutional Review Board before award commencement.
10. National Lung Cancer Partnership will not discriminate on the basis of gender, race, creed, religion, sexual orientation, disability, nationality, age or any other factor irrelevant to the quality of the application.

National Lung Cancer Partnership
222 N. Midvale Blvd., Suite 6
Madison, WI 53705

Phone: 608.233.7905
Fax: 608.233.7893

E-mail: info@NationalLungCancerPartnership.org
www.NationalLungCancerPartnership.org

American Association for Cancer Research-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention

AACR and the American Cancer Society established this Award in 1992 to honor outstanding research accomplishments in the fields of cancer epidemiology, biomarkers, and prevention.

The winner of the 20th Annual AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention will receive an honorarium of $5,000, give a 50-minute lecture, and be given support for the winner and a guest to attend the AACR Annual Meeting 2011, in Orlando, FL, USA (April 2-6, 2011).

Eligibility

* Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
* The Award will be presented to an individual investigator.
* Institutions or organizations are not eligible for the Award.

Nomination Process

Nominations for the 2011 Award opens August 2010.

Nominations may be made online via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nominations must be submitted online at https://proposalcentral.altum.com, no later than 4:00 p.m. United States Eastern Time on Thursday, September 30, 2010. Paper nominations will not be accepted. The following materials must be submitted:

Nomination Letter, which must:

* be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
* specify the AACR Award for which the candidate is being nominated;
* a concise description of the candidate's outstanding cancer research accomplishments in the fields of epidemiology, biomarkers, and prevention, with the publications supporting these accomplishments directly referenced within the letter; and
* a concise description of the impact of these accomplishments on the field.

Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.

Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.

Preferred file formats are *.doc. The candidate's CV may be submitted as a .pdf file. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

Nomination Instructions

Will be available in August 2010.

Selection

Candidates will be considered by a Committee of international cancer leaders appointed by the President of the AACR. After careful deliberations by the Award Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's cancer research accomplishments in the fields of epidemiology, biomarkers, and prevention. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.

Supporter

Generously supported by the American Cancer Society.

Questions?

Monique P. Eversley, Program Coordinator
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404

American Association for Cancer Research Award for Outstanding Achievement in Chemistry in Cancer Research

AACR and its Chemistry in Cancer Research Working Group established this Award in 2007 to recognize the importance of chemistry to advancements in cancer research. The Award will be given for outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer. Such research may include, but is not limited to, drug discovery and design; structural biology; proteomics, metabolomics and biological mass spectrometry; chemical aspects of carcinogenesis; imaging agents and radiotherapeutics; and chemical biology.

The winner of the Fifth Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research will give a 50-minute lecture during the AACR 102nd Annual Meeting 2011 in Orlando, FL, USA (April 2-6, 2011), will receive a commemorative plaque and a $10,000 honorarium, and receive support for the winner and a guest to attend the Annual Meeting.

Eligibility Criteria

* Candidacy is open to all researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
* The Award will be presented to an individual investigator. Two or more individuals may be selected to share the Award when their investigations are closely related in subject matter and have resulted in work worthy of an award.
* Institutions or organizations are not eligible for the Award.
* Selection of the Award winner will be made on the outstanding quality, novelty, and significance of the candidates' chemistry research and its important contributions to cancer research. No regard will be given to race, gender, nationality, geographic location, or religious or political views.
* Prior recipients of the AACR-Bruce F. Cain Memorial Award are not eligible to be nominated for research previously recognized by the Cain Award.

Nomination Process

Nominations may be made via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nomination letters must be sent electronically to awards@aacr.org by Friday, October 15, 2010, at 4:00 p.m., United States Eastern Time. Preferred file formats are *.doc, *.pdf. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days.

The following materials must be submitted:

* The nomination letter must be addressed to the Selection Committee; be written in English; and not exceed 1,000 words. The content should include the following:
o the name of the AACR Award for which the candidate is being nominated;
o a brief statement of no more than 50 words summarizing the candidate's cancer research accomplishment(s) for which he or she is being nominated;
o a concise description of the candidate's outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer, with the publications supporting these accomplishments directly referenced within the letter; and
o a concise description of the impact of these accomplishments on the field.
* The candidate's curriculum vitae in English, including a complete list of the candidate's publications; and
* A summary statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates who may be nominated by any individual scientist. There is no restriction on the number of nominators who may write nomination letters or who may sign a single nomination letter on behalf of a candidate.

If two or more candidates are nominated to share the award, a curriculum vitae and full publication history for all candidates must be submitted along with a combined letter of recommendation that fulfills the above criteria and clearly outlines how the work of the individuals is related and is worthy of the Award.

Selection

Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. The Committee will consider all nominations as they have been submitted; the Committee may not combine submitted nominations, add a new candidate to a submitted nomination, or otherwise make alterations to the submitted nominations. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's outstanding, novel, and significant chemistry research related to cancer. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.

The winner of the Fifth Annual AACR-CICR Award will be announced in January 2011.
Supporter

Generously supported by GlaxoSmithKline.

Questions?

Lauren Medvetz, Program Coordinator
+1 (267) 646-0689; lauren.medvetz@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404